Glaucoma surgery checked 5 years later: does it hold up?
NCT ID NCT07480343
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 250 people with open-angle glaucoma who had a new type of surgery called CycloPen, which aims to improve fluid drainage from the eye. Researchers will measure eye pressure at 3, 4, and 5 years after surgery to see if the benefits last. The goal is to understand how well this procedure controls glaucoma over the long term.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could show that the CycloPen surgery provides lasting pressure control for glaucoma patients, potentially reducing the need for daily eye drops.
What could go wrong
This is an observational follow-up, not a new treatment test. It only includes patients who already did well initially, so results may not apply to everyone with glaucoma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN ANGLE GLAUCOMA (OAG) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CREST-XT Site 01
Fort Washington, Pennsylvania, 19034, United States
-
CREST-XT Site 03
Cape Coral, Florida, 33904, United States
-
CREST-XT Site 04
Crossville, Tennessee, 38555, United States
-
CREST-XT Site 05
Newport Beach, California, 92663, United States
-
CREST-XT Site 07
Atlanta, Georgia, 30342, United States
-
CREST-XT Site 11
Salt Lake City, Utah, 84132, United States
-
CREST-XT Site 12
Chevy Chase, Maryland, 20815, United States
-
CREST-XT Site 13
Rockville, Maryland, 20852, United States
-
CREST-XT Site 15
New York, New York, 10034, United States
-
CREST-XT Site 16
Las Vegas, Nevada, 89145, United States